PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of transahomepageaboutsubmitalertseditorial board
 
Philos Trans A Math Phys Eng Sci. Nov 28, 2011; 369(1955): 4407–4424.
PMCID: PMC3263786
Haemoglobin oxygen saturation as a biomarker: the problem and a solution
David A. Boas* and Maria Angela Franceschini
Optics Division of the Martinos Center for Biomedical Imaging, Harvard Medical School, Massachusetts General Hospital, 149 13th St rm 2301, Charlestown, MA 02129
*Author for correspondence (dboas/at/nmr.mgh.harvard.edu).
One contribution of 20 to a Theo Murphy Meeting Issue ‘Illuminating the future of biomedical optics’.
Near-infrared spectroscopy measures of haemoglobin oxygen saturation are often used as an indicator of sufficient oxygen delivery to assess injury susceptibility and tissue damage. They have also often been used as a surrogate measure of oxygen metabolism. Unfortunately, these measures have generally failed to provide robust indicators of injury and metabolism. In this paper, we first review when haemoglobin oxygen saturation does work as a robust indicator, and then detail when and why it fails for assessing brain injury and breast cancer. Finally, we discuss the solution to obtain more robust measures of tissue injury and cancer by combining oxygen saturation measurements with measures of blood flow and volume to more accurately estimate oxygen metabolism.
Keywords: near-infrared spectroscopy, haemoglobin oxygen saturation, oxygen metabolism, muscle, breast, brain
Oxidative metabolism provides more than 90 per cent of ATP production in aerobic organisms. A sensor of cellular oxygen and oxygen utilization has long been sought because of its importance in studying cellular energetics. A non-invasive oxygen sensor would have significant clinical utility for assessing tissue injury and disease that give rise to impaired oxygen delivery and/or utilization, and would be important for following tissue response to therapy. In 1977, Jobsis [1] first exploited the weak absorption of tissue in the near infrared to measure cytochrome c oxidase (CCO) in an intact organ, the feline brain, thus initiating the development of near-infrared spectroscopy (NIRS). Cytochrome oxidase is an important oxygen sensor because it reacts directly with oxygen at the terminus of the cellular respiratory chain. An insufficient supply of oxygen would lead to a build-up of reduced CCO. Oxidized CCO has an absorption band around 840 nm that decreases when CCO is reduced. Thus, it appeared that NIRS would provide the long-sought non-invasive oxygen sensor.
The technique for measuring CCO was quickly translated to the clinical environment to assess whether neonates in the intensive care unit had a sufficient supply of oxygen to the brain [2]. It was observed that hypoxia in these infants led to a more reduced state of CCO, as expected. Following this work, several other groups started using NIRS in the clinic [3,4]. In order to estimate the oxidized or reduced state of CCO, it was also necessary to untangle the contributing effects of oxygenated and deoxygenated haemoglobin (HbO and HbR, respectively) to the near-infrared absorption spectrum. This is a challenging task because of the low in vivo concentration of CCO relative to haemoglobin. But by measuring the light absorption at several wavelengths and correcting for the path length of light through the tissue at the different wavelengths, it is in principle possible to separate the spectroscopic signatures of the chromophores and estimate their in vivo concentrations [5]. By 1995, several different algorithms had been developed for estimating the concentrations with path length correction factors that varied with the particular application. This raised concerns that using the wrong algorithm could give rise to artefacts in the estimated CCO concentration. This was evidenced by Skov & Greisen [6], who found that the switch to cardiopulmonary bypass in hypoxaemic children with congenital heart disease led to a decrease in oxidized CCO, despite an improvement in cerebral oxygen delivery as indicated by an increase in the cerebral oxygenation index (i.e. HbO – HbR). They suggested that this non-physiological finding was probably a result of using an incorrect algorithm that did not accurately separate the confounding effects of HbO and HbR and total haemoglobin concentration (HbT=HbO+HbR) when estimating CCO. Matcher et al. [7] quantified the errors that arise from using the wrong algorithm, which supported the growing sense that in vivo quantification of CCO was not reliable.
While a few researchers continue the effort to improve the reliability of in vivo CCO quantification through multi-spectral measurements that robustly estimate and correct for wavelength-specific path length factors [8,9], NIRS use shifted to measuring haemoglobin oxygen saturation (SO2=HbO/HbT) as a surrogate for tissue oxygenation and utilization for applications in the brain, muscle and breast. The rationale was clear. Oxygen utilization with insufficient oxygen delivery would certainly result in reduced oxygenation of haemoglobin. Further, since the haemoglobin chromophores dominated the absorption spectrum in the near infrared, the estimate of SO2 was less susceptible to algorithm errors, although partial volume effects [10], myoglobin [11] and the presence of other chromophores [12] can still confound the estimation of SO2. Finally, a decrease in SO2 was generally associated with an increase in the reduced form of CCO [1,2,4].
It is becoming apparent that SO2 alone is not a robust indicator of sufficient oxygen delivery to the tissue [13]. In many cases, HbT and blood flow (BF) are proving to be better indicators of tissue status [14,15], and even better when combined with SO2 to estimate oxygen consumption (OC) [1618]. Below, we review when SO2 works and when it should be replaced by more robust measures of OC. While, historically, the first and major focus of NIRS was to study the brain haemoglobin oxygen saturation (see [19] and [20] as recent reviews), we begin with the NIRS work in muscle, proceed to the application to breast cancer, and finish with efforts in the brain.
Skeletal muscle is strongly dependent on oxidative metabolism. Muscle OC can increase 50-fold during exercise [21]. Any disruption of normal oxygen delivery or consumption is likely to adversely affect exercise tolerance. Training is known to improve muscle tolerance to increased energetic demands from exercise, and NIRS is being used to assess muscle ability to adequately support metabolic demands with the potential of using NIRS to guide and optimize individual training [22,23]. A number of chronic health conditions impair oxygen delivery to the muscle, including peripheral vascular disease [24] and chronic heart failure [25].
Resting SO2 alone fails to detect disease-induced differences in oxygen delivery or utilization, probably owing to the large differences in fat and muscle distribution within and across individuals [26]. An advantage with peripheral muscle is the possibility of performing manipulations that allow a direct measure of OC. In fact, estimating OC from NIRS measurements of oxygenated haemoglobin is a common practice in muscle applications. Pressure cuff occlusion of BF in an arm or leg is an easy means of measuring tissue OC. The method is quite simple, as described in Cheatle et al. [27], De Blasi et al. [28] and Casavola et al. [29]. Rapidly increasing cuff pressure above arterial blood pressure will occlude BF in the extremity with no associated change in total haemoglobin concentration. A NIRS measurement downstream of the occlusion will reveal a resultant increase in HbR and a decrease in HbO owing to OC. If the pressure was increased sufficiently rapidly above arterial pressure, then there will be no change in total haemoglobin concentration HbT=HbO+HbR. The rate of decrease of HbO will thus be directly related to OC,
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e1.jpg
2.1
where the 4 accounts for the haemoglobin to oxygen molar ratio. An example of this is shown in figure 1. Similar to the experiment described in Casavola et al. [29], an ISS Inc. frequency-domain instrument was used to quantify the HbO and HbR concentrations in leg muscle during a pressure cuff occlusion. The cuff pressure was rapidly raised to 240 mm Hg, sufficient to occlude venous and arterial BF. This pressure was maintained for approximately 8 min, as indicated by the shaded area in figure 1. Very little change in HbT was observed, confirming that arterial flow was rapidly occluded. During the first few minutes, the concentration of HbO/HbR was seen to linearly decrease/increase. Using equation (2.1), the OC in the leg muscle was calculated to be An external file that holds a picture, illustration, etc.
Object name is rsta20110250-i1.jpg.
Figure 1.
Figure 1.
Changes in the haemoglobin concentrations in leg muscle during an 8 min pressure cuff occlusion of arterial and venous blood flow. The occlusion occurred during the period indicated by the shaded box. During this period, deoxyhaemoglobin increased and (more ...)
A partial pressure cuff occlusion will result in changes in HbT if the arteries are not fully occluded, thus allowing blood to flow in, but veins are occluded preventing blood from flowing out. In this case, De Blasi et al. [28] and Casavola et al. [29] have indicated that it is still possible to estimate OC provided that a correction is made for HbT changes. Specifically, any increase in HbT will result from inflowing arterial blood. Since this haemoglobin is not fully oxygenated, it will increase HbR. If we first subtract this contribution to the change in HbR, then OC can be accurately estimated
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e2.jpg
2.2
where SaO2 is the arterial haemoglobin oxygen saturation.
Previous to this, De Blasi et al. [28] have tested the possibility of estimating OC during muscle exercise without using occlusion. The results are encouraging, showing similar results with and without occlusion. While there was no occlusion and thus generally the inflowing blood cannot be neglected, they still estimated OC using equation (2.1). We revisit this later in §5 below, but briefly this works because the increase in OC is sufficiently large that the effects of inflowing and outflowing blood can be neglected during the early transient.
Tumour physiology is marked by increased vascularization and hypoxia. Historically, blood volume (BV) by itself, as an indicator of increased vascularization, has not robustly detected and distinguished malignant and benign lesions [30,31]. Several papers suggest the importance of haemoglobin oxygenation for making the distinction, with the expectation that the hypoxic tissue environment of the tumour would be reflected by reduced haemoglobin oxygen saturation [3235]. One of the first papers to report tumour SO2 versus healthy tissue found a reduction in SO2 [32]. In a follow-up report of 58 patients, this reduction in SO2 was not found to be significant [36].
Imaging studies reported by four other groups over the past 10 years have confirmed that SO2 is not significantly different in malignant lesions versus healthy tissues or benign lesions. These results are summarized in figure 2. The results from 93 patients reported by Grosenick et al. [37] and from 49 patients reported by Intes [38], both using time-domain optical transmission imaging systems, are shown in figure 2a,b. Figure 2c summarizes the results from 14 patients reported by Ntziachristos et al. [39] using a time-domain optical transmission imaging measurement combined with magnetic resonance imaging. Figure 2d presents the results from 116 patients reported by Chance et al. [40] using a continuous-wave optical imaging system in reflectance mode. From these plots, it is clear that there is significant overlap among healthy, benign and malignant lesions, when considering only SO2. Some of the studies reveal that this overlap is diminished when considering only HbT.
Figure 2.
Figure 2.
The results from four different optical breast imaging studies of malignant lesions compared with benign lesions and healthy tissue are presented in scattered plots of SO2 versus HbT. Details of the studies are provided in the text. While SO2 alone generally (more ...)
What is striking when examining these four different imaging studies is the significant separation of malignant lesions from benign lesions and healthy tissue when considering SO2 and HbT simultaneously, a point also suggested by Cerussi et al. [36]. Note, in figure 2, the trend showing that tumour SO2 is low when tumour HbT is comparable to non-malignant tissue and that tumour SO2 is higher and can exceed non-malignant tissue SO2 when tumour HbT is higher. This is a result of hyperperfusion, reflected by an increase in HbT, increasing oxygen delivery to the tissue beyond the increase in oxygen demand. This is an important result that we will return to in §5 that SO2 can actually increase despite an increase in tissue oxygen metabolism and a possible decrease in tissue oxygenation. It is because of the confounding impact of BF on oxygen delivery that baseline SO2 alone is not a robust measure of oxygen metabolism or sufficient oxygen delivery.
While baseline SO2 alone does not differentiate breast disease, it may be possible to manipulate BF to induce changes in SO2 that can reveal the metabolic needs of breast lesions. This manipulation would be analogous to the pressure cuff occlusion done in muscle studies. This possibility is suggested by Carp et al. [41], who reported that mild breast compression partially occludes BF and produces a transient decrease in SO2. By fitting the temporal decay of SO2 with an oxygen mass balance equation, it is then possible to estimate tissue OC and BF. Future development of this approach in breast imaging will probably provide new biomarkers, OC and BF, for differentiating lesions.
A continuous supply of oxygen is critical to the health of the brain. As the brain has no store of oxygen, any disruption in supply would quickly result in tissue oxygen depletion and metabolic stress as the brain under anaerobic glycolysis would not be able to produce sufficient energy to maintain normal cell function. Thus, maintaining oxygen supply and utilization in the brain is a major goal when treating brain injury, during cardiac surgery and during general anaesthesia. The first attempt to use NIRS to obtain a more direct measure of brain oxygen delivery and utilization, rather than rely on measurements of oxygen content at sites distant from the brain (e.g. pulse oximetry and blood gases), was in 1985 when Brazy et al. [2] used NIRS in the neonatal intensive care unit. They used a three-wavelength NIRS device with 775, 815 and 904 nm to achieve sensitivity to changes in HbO, HbR and CCO. In this way they could monitor changes in oxygen delivery as reflected by the oxygen saturation SO2 and total haemoglobin, as well as changes in oxygen utilization as indicated by the CCO concentration. Their results during brief apnoea in infants showed expected reductions in SO2 and CCO, with a prolonged recovery of CCO relative to SO2. As discussed in §1, subsequent studies revealed that the estimate of CCO was unreliable [7] and therefore clinical measures with NIRS focused on using only SO2.
One example of the usefulness of NIRS measures of cerebral SO2 is in assessing collateral perfusion through the circle of Willis during carotid endarterectomy [4244] or carotid balloon occlusion test [4548]. This is an important test before carotid surgery since insufficient collateral perfusion during the surgery would result in ischaemic damage to the brain. Immediately following carotid occlusion, NIRS reveals a decrease in SO2 in the ipsilateral cortex. In patients with sufficient collateral perfusion, SO2 generally returns to the baseline value within a minute during the occlusion. In patients with insufficient collateral perfusion, the SO2 remains below the baseline value for the duration of the occlusion. An experimental example is shown in figure 3. Changes in HbT and HbR are shown for 1 min before and 2 min after total balloon occlusion of the patient's right internal carotid artery. At the onset of the occlusion, we observe a dramatic drop in HbT with little change in HbR. As the occlusion reduces the perfusion pressure, the compliant vessels contract reducing HbT. The corresponding little change in HbR indicates that SO2 has dropped as expected owing to an increased extraction fraction to maintain a constant oxygen delivery. In this patient, however, collateral perfusion through the circle of Willis responds within 30 s, producing a hyperaemic overshoot in HbT with a corresponding decrease in HbR, with everything returning to baseline levels within 2 min, although the right internal carotid is still occluded.
Figure 3.
Figure 3.
The changes in HbT and HbR observed over the right frontal cortex are shown for 1 min before and 2 min after total balloon occlusion of the patient's right internal carotid artery. HbT is seen to initially drop, and then overshoot during (more ...)
NIRS measures of cerebral SO2 have also demonstrated the ability to assess delivery of oxygen to the brain during cardiac surgery [4953]. During cardiopulmonary bypass surgery, drops in SO2 serve as an indicator of reduced BF to the brain that can be corrected by the surgical team. Following bypass surgery, the SO2 then provides assurance of the success of the surgery to restore and maintain sufficient oxygen delivery to the brain. While the changes in SO2 clearly correspond with cardiac surgery, there is no clear conclusion as to the utility of using these measures to predict the outcome of the patient. In infants, the outcome of the patient probably depends more on the cerebral damage acquired from insufficient cardiac output before the surgery than on maintaining cerebral perfusion during the surgery [49]. In adults, a recent randomized, prospective study has demonstrated that patients with a lower mean SO2 during the surgery had a longer length of stay in the hospital after the surgery owing to a greater incidence of major organ dysfunction [51]. For adults, further study is needed to optimize neuro-monitoring feedback during cardiac surgery, particularly to better understand the importance of decreased cerebral oxygenation versus cerebral emboli as the cause of neurological injury [50], the latter of which requires transcranial ultrasound to detect.
Neonates in the intensive care unit receive numerous interventions that can have an impact on oxygen delivery to the brain, such as manipulation of haematocrit and blood pressure, yet the impact on the brain is not directly measured nor is it understood. Thus, the possibility exists that such interventions could adversely affect the patient. Wardle et al. [54] measured cerebral SO2 in anaemic and hypotensive neonates and found no significant difference with respect to normal controls, suggesting that cerebral autoregulation maintained oxygen delivery. When infants are asphyxiated at birth, an increase in cerebral SO2 relative to healthy controls has been observed to correlate with abnormal outcome [55]. In a different study, a reduction in SO2 relative to healthy controls on the first day of life correlated with severity of a subsequently developed intraventricular haemorrhage [56]. While these results indicate the possibility of using SO2 to identify those patients who need aggressive treatment, there was significant overlap in the SO2 values with infants that had normal outcome. To prevent over-treatment, it has been suggested that NIRS instruments need to be improved to provide a more precise measure of SO2 in order to distinguish subtle differences with more power [57]. An important relevant observation is that the measured SO2 can vary by more than 10 per cent with repeated placement of the optodes, presumably because of subtle differences in underlying tissue heterogeneity [57,58], thus indicating the need to reduce this variation through repeated probe placement or spatially resolved oximetry [56].
By introducing a blood tracer with optical contrast, NIRS measurements can be made to estimate BF and BV. Oxygen is an ideal tracer to use with NIRS to estimate BF and BV, as detailed by Reynolds et al. [59] and Wyatt et al. [60], respectively. An early demonstration of the predictive power of BF and BV from Meek et al. [14] showed that increases in BF and BV above normal levels in infants with perinatal asphyxia correlated with adverse outcome of the infants. They suggest that acute hypoxia–ischaemia releases several vasoactive agents, resulting in the most severely affected infants having the greatest cerebral hyperaemia. While these results demonstrate the promising potential of NIRS for assessing brain injury in newborns, they state that BV measurements as an early marker of the severity of perinatal asphyxia are of limited value because of a poor specificity of 38 per cent (sensitivity of 85%) and the poor reproducibility in making such oxygen manipulations. They suggest that upcoming advances in NIRS technology may make it possible in the future to improve specificity by obtaining absolute haemoglobin concentrations and obtaining more direct measures of oxygen extraction fraction and oxygen metabolism [61,62] without the need for introducing a blood tracer.
Multi-distance frequency-domain technology provides a means to estimate absolute absorption and scattering properties of the tissue, and thus estimate absolute haemoglobin concentrations without the need for vascular tracers [63]. This technology offers a robust approach to estimate cerebral BV and oxygenation in infants, as demonstrated by measures of the twofold increase in cerebral BV in the first year of life by Franceschini et al. [64]. Grant et al. [15] used this approach to measure alterations in cerebral BV and SO2 in newborns with a variety of brain injuries compared with infants without brain injury. Consistent with the earlier work of others, they found no significant difference in SO2 between the infants with brain injury and the stable control infants without brain injury. Similar to Meek et al. [14], they also found that cerebral BV was significantly elevated in the brain-injured infants, but, because no vascular tracers are needed, it is now possible to apply this approach to all patients.
From the above examples, we have seen that, when there are transient changes in BF or OC, changes in haemoglobin oxygenation can reveal information about oxygen delivery and consumption. It is important to emphasize that, here, transient refers to the SO2 changes that occur during the first minutes of the oxygen delivery or consumption change.
Generally, OC can be estimated by the difference between the quantity of oxygen being delivered by the arteries and that drained by the veins in a tissue of interest. In a steady state, OC can be calculated from the flow of blood multiplied by the difference between the arterial oxygen saturation (SaO2) and the venous oxygen saturation (SvO2), where the saturations are given as a fraction. That is,
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e3.jpg
5.1
where HGB is the haemoglobin concentration in the blood (g l−1) and MWHb is the molecular weight of haemoglobin (g mol−1) and the 4 accounts for the haemoglobin to oxygen molar ratio. An abrupt change in BF (l 100 g−1 min−1) or OC (mol O2 100 g−1 min−1), as can result from a pressure cuff occlusion or exercise, will result in an imbalance of the left- and right-hand side of equation (5.1), thus giving rise to temporal changes in HbO and HbR. The temporal changes are described by Carp et al. [41]
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e4.jpg
5.2
Subject to the conditions that BF and/or OC change abruptly at t=0 and then remain constant, we obtain the solution linearized for small changes in HbO and SvO2, as occurs at time scales that are short compared with oxygen delivery and consumption time scales,
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e5.jpg
5.3
Here, for simplicity, we assume that the haemoglobin saturation measured by NIRS is the volume fraction weighted average of SaO2 and SvO2, i.e. SO2=VFASaO2+VFVSvO2, where VFV(VFA) is the venous (arteriole) volume fraction and VFV+VFA=1. The subscript ‘o’ refers to the initial value. During a pressure cuff arterial occlusion, BF=0 and we arrive at the same equation relating OC to ΔHbO(t) as used in muscle studies (equation (2.1) above). We still arrive at the same equation, if the rate of OC, i.e. 1/4 OC, is much greater than the rate of oxygen delivery,
A mathematical equation, expression, or formula.
 Object name is rsta20110250-e6.jpg
as demonstrated by De Blasi et al. [28], when estimating OC during exercise with and without cuff occlusion. These equations demonstrate formally when we can use transient changes in SO2 (or HbR) to estimate OC.
For measurements of the brain or breast, it is generally not feasible to introduce an abrupt change in BF or OC. As a result, we must rely on equation (5.1) and use measurements of SO2 combined with measurements of BF to estimate OC. The need for combining these measurements is nicely illustrated by the breast imaging studies depicted in figure 2. While it was reasonable to expect to observe a decreased SO2 because of increased metabolic activity in the tumour, this was not observed because of the confounding effect of BF. Higher BF, as suggested by an increased HbT, increases oxygen delivery and thus SO2. By considering both BF and SO2, as we did with the diagonal line separating malignant breast lesions from the healthy tissue and benign lesions in figure 2, we see that malignant lesions are generally consuming more oxygen.
Recognizing the confounding effect of BF on estimating OC from SO2, Grant et al. [15] applied equation (5.1), using BV as a surrogate measure of BF, to estimate changes in OC in brain-injured infants relative to healthy controls and found that OC was significantly elevated. The summary of results from 14 brain-injured infants compared with 29 infants without brain disorders is shown in figure 4. These infants were in the acute stage of brain injury and so the observation of elevated BV and OC suggests that the brain disorders measured shared a common mechanism of hyperperfusion, possibly arising from increased neuronal activity owing to excitotoxic processes evolving in the tissue over days. In the chronic stage after approximately 7 days, they have observed that OC drops to zero, thus providing a time scale for cell death in these injuries.
Figure 4.
Figure 4.
Measurements of cerebral OC versus blood volume (BV) are shown for acutely brain-injured newborns compared with newborns without brain injury. OC is reported relative to healthy age-matched controls. In general, acutely brain-injured newborns have increased (more ...)
As discussed by Leung et al. [65] and Boas & Payne [66], care must be taken in estimating BF from BV. It is common to use the Grubb relation [65,67], but this relation may not be valid under all conditions [68], particularly patho-physiological conditions. Thus, it is preferable to obtain independent measures of BF as offered by diffuse correlation spectroscopy (DCS) when estimating OC [18]. A recent example by Roche-Labarbe et al. [17] in neonates during the first six weeks of life nicely demonstrates first the uncoupling that can arise between BF and BV, and second the improved estimates of OC that can be obtained with independent measures of BF, HbT and SO2. Fifty-six premature infants were measured longitudinally during their hospital stay for a total of 230 measurements. Figure 5 reports average results as a function of corrected gestational age (cGA) for BV measured with the frequency-domain multi-distance method, an index of blood flow (BFi) measured with DCS, and the relative OC calculated with respect to infants born at 35 weeks GA. OC was calculated using either BFi measured by DCS or using Grubb's relation to estimate BF from the measured BV. Figure 5a,b shows the uncoupling between BV and BF, with BV more or less constant with cGA and BF increasing with age. This uncoupling is probably due to the large decreases in haematocrit during the first two months of life, which alter haemoglobin content and blood viscosity. As a result, in the newborn population, quantifying OC using BV as a surrogate for BF not only gives an incorrect result, but also produces a larger variance in OC as shown in figure 5c,d.
Figure 5.
Figure 5.
Plotted are average results of (a) BV and (b) blood flow index (BFi) measured on 56 newborn premature infants and measured longitudinally over several weeks on each infant. Standard errors are indicated except for the last 2 points, which are from single (more ...)
As another example of combining measures of BF with SO2 to estimate OC, Zhou et al. [69] combined DCS with frequency-domain NIRS to measure breast tumour response to chemotherapy. The results from a single patient are shown in figure 6 following the tumour response from baseline on day 0 to 7 days after chemotherapy. A significant decrease in HbT and SO2 is observed during the first 7 days following chemotherapy. Interestingly, BF first significantly increased on day 3 and then decreased below baseline on days 4–7, revealing an uncoupling between HbT and BF that could be a result of a reduced haematocrit following chemotherapy [70], changes in vascular morphology and resistance, changes in intra-tumour pressure or a complex combination of these factors. The estimate of OC revealed that it first increased on day 3 and then decreased below baseline, suggesting a complex metabolic response to the therapy that is interesting for better understanding tumour response to therapy and will potentially help to better identify therapy responders from non-responders in the first week of therapy.
Figure 6.
Figure 6.
Breast tumour response to chemotherapy, as measured from a single patient, reveals an increase in BF and OC on day 3 following therapy, which then reduces below baseline along with HbT and SO2. These results are a composite of the results presented in (more ...)
As suggested by the above-mentioned studies, multi-modal estimates of OC will enable new physiological studies in health and disease leading to new diagnostic and therapeutic approaches. One interesting physiological finding is the constancy of SO2 in developing human infants over the first year of life despite a doubling of BV [64] and a presumed twofold to fourfold increase in BF. This observed tight coupling of oxygen demand and oxygen supply to maintain a constant SO2 suggests that SO2 is an important factor in the regulation of BF over a long-term time scale [71]. This tight coupling has recently been observed at the level of the microvasculature by Yaseen et al. [72], in which, in individual rats, BF in distinct ascending venules draining the cortex can vary by 20-fold over a distance of 500 μm, yet SO2 within those individual draining venules is constant. These results indicate that oxygen demand in a volume of tissue drained by a given ascending venule is matched to the flow in that venule to maintain a constant SO2. These are provocative results that are likely to be relevant to pathological conditions where chronic hypoxia may be resulting in angiogenesis to normalize SO2.
NIRS has tantalized us with the prospect of obtaining non-invasive measurements of an important oxygen sensor, CCO. Work continues to realize a robust measure of CCO that can be used routinely in humans. Until that is achieved, NIRS efforts have instead used the far more robust measures of haemoglobin SO2 as a surrogate tissue oxygen sensor. As we have discussed in this paper, when there is an abrupt change in BF or OC, transient changes in SO2 can reveal information about tissue OC. However, when abrupt changes in BF or OC are not feasible, or the measurement cannot be made in the first minute, then inference of tissue OC or sufficient oxygen delivery from SO2 measures alone is confounded by BF. This is nicely illustrated by studies of SO2 in asphyxiated newborn infants revealing a slight increase in SO2 relative to healthy controls, which has been interpreted as a reduction in oxygen demand from cerebral injury leading to cellular energy failure. Alternatively, the injury could elicit a strong BF response to overcompensate for an increased metabolic demand. Thus, generally speaking, in order to robustly assess tissue OC and sufficient oxygen delivery, it is necessary to measure both SO2 and BF. More and more groups are now exploiting all optical methods, and optical methods combined with other imaging modalities, to obtain this important physiological measurement and use it in a broad range of applications.
Acknowledgements
Britton Chance's leadership in biomedical optics and mitochondrial respiration has inspired us in our endeavour to translate optical methods to the clinic and to unravel the dynamic energetic processes in health and disease. We will miss him but are comforted by the opportunity to follow in his giant footsteps. In preparing this presentation and manuscript, we are grateful for the assistance of and discussions from Juliette Selb, Nadege Roche-Labarbe, Ellen Grant, Abbas Yaseen, Bruce Tromberg, Arjun Yodh and Marco Ferrari. We acknowledge support from the National Institute of Health under R01-EB06385, P41-14075, R01-HD042908, R01-NS057476 and P01-NS055104.
1. Jobsis F. F. 1977. Nonivasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters Science 1981264–1267.1267 (doi:10.1126/science.929199) doi: 10.1126/science.929199. [PubMed] [Cross Ref]
2. Brazy J. E., Lewis D. V., Mitnick M. H. Noninvasive monitoring of cerebral oxygenation in preterm infants: preliminary observations. Pediatrics. 1985;75:217–225. [PubMed]
3. Ferrari M., Giannini I., Sideri G., Zanette E. Continuous non invasive monitoring of human brain by near infrared spectroscopy. Adv. Exp. Med. Biol. 1985;191:873–882. [PubMed]
4. Wyatt J. S., Cope M., Delpy D. T., Wray S., Reynolds E. O. R. 1986. Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry Lancet 21063–1066.1066 (doi:10.1016/S0140-6736(86)90467-8) doi: 10.1016/S0140-6736(86)90467-8. [PubMed] [Cross Ref]
5. Wray S., Cope M., Delpy D. T., Wyatt J. S., Reynolds E. O. 1988. Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation Biochim. Biophys. Acta. 933184–192.192 (doi:10.1016/0005-2728(88)90069-2) doi: 10.1016/0005-2728(88)90069-2. [PubMed] [Cross Ref]
6. Skov L., Greisen G. 1994. Apparent cerebral cytochrome aa3 reduction during cardiopulmonary bypass in hypoxaemic children with congenital heart disease. A critical analysis of in vivo near-infrared spectrophotometric data Physiol. Meas. 15447–457.457 (doi:10.1088/0967-3334/15/4/006) doi: 10.1088/0967-3334/15/4/006. [PubMed] [Cross Ref]
7. Matcher S. J., Elwell C. E., Cooper C. E., Cope M., Delpy D. T. 1995. Performance comparison of several published tissue near-infrared spectroscopy algorithms Anal. Biochem. 22754–68.68 (doi:10.1006/abio.1995.1252) doi: 10.1006/abio.1995.1252. [PubMed] [Cross Ref]
8. Cooper C. E., et al. 1999. Use of mitochondrial inhibitors to demonstrate that cytochrome oxidase near-infrared spectroscopy can measure mitochondrial dysfunction noninvasively in the brain J. Cereb. Blood Flow. Metab. 1927–38.38 (doi:10.1097/00004647-199901000-00003) doi: 10.1097/00004647-199901000-00003. [PubMed] [Cross Ref]
9. Tachtsidis I., Tisdall M., Leung T. S., Cooper C. E., Delpy D. T., Smith M., Elwell C. E. 2007. Investigation of in vivo measurement of cerebral cytochrome-c-oxidase redox changes using near-infrared spectroscopy in patients with orthostatic hypotension Physiol. Meas. 28199–211.211 (doi:10.1088/0967-3334/28/2/008) doi: 10.1088/0967-3334/28/2/008. [PubMed] [Cross Ref]
10. Strangman G., Franceschini M. A., Boas D. A. 2003. Factors affecting the accuracy of near-infrared spectroscopy concentration calculations for focal changes in oxygenation parameters Neuroimage 18865–879.879 (doi:10.1016/S1053-8119(03)00021-1) doi: 10.1016/S1053-8119(03)00021-1. [PubMed] [Cross Ref]
11. Hoofd L., Colier W., Oeseburg B. A modeling investigation to the possible role of myoglobin in human muscle in near infrared spectroscopy (NIRS) measurements. Adv. Exp. Med. Biol. 2003;530:637–643. [PubMed]
12. Ferrari M., Mottola L., Quaresima V. 2004. Principles, techniques, and limitations of near infrared spectroscopy Can. J. Appl. Physiol. 29463–487.487 (doi:10.1139/h04-031) doi: 10.1139/h04-031. [PubMed] [Cross Ref]
13. Weiss M., Dullenkopf A., Kolarova A., Schulz G., Frey B., Baenziger O. 2005. Near-infrared spectroscopic cerebral oxygenation reading in neonates and infants is associated with central venous oxygen saturation Paediatr. Anaesth. 15102–109.109 (doi:10.1111/j.1460-9592.2005.01404.x) doi: 10.1111/j.1460-9592.2005.01404.x. [PubMed] [Cross Ref]
14. Meek J. H., Elwell C. E., McCormick D. C., Edwards A. D., Townsend J. P., Stewart A. L., Wyatt J. S. 1999. Abnormal cerebral haemodynamics in perinatally asphyxiated neonates related to outcome Arch. Dis. Child Fetal Neonatal Ed. 81F110–F115.F115 (doi:10.1136/fn.81.2.F110) doi: 10.1136/fn.81.2.F110. [PMC free article] [PubMed] [Cross Ref]
15. Grant P. E., Roche-Labarbe N., Surova A., Themelis G., Selb J., Warren E. K., Krishnamoorthy K. S., Boas D. A., Franceschini M. A. 2009. Increased cerebral blood volume and oxygen consumption in neonatal brain injury J. Cereb. Blood Flow. Metab. 291704–1713.1713 (doi:10.1038/jcbfm.2009.90) doi: 10.1038/jcbfm.2009.90. [PMC free article] [PubMed] [Cross Ref]
16. Yoxall C. W., Weindling A. M. 1998. Measurement of cerebral oxygen consumption in the human neonate using near infrared spectroscopy: cerebral oxygen consumption increases with advancing gestational age Pediatr. Res. 44283–290.290 (doi:10.1203/00006450-199809000-00004) doi: 10.1203/00006450-199809000-00004. [PubMed] [Cross Ref]
17. Roche-Labarbe N., Stefan A., Carp S. A., Surova A., Patel M., Boas D. A., Grant P. E., Franceschini M. A. 2010. Noninvasive optical measures of CBV, StO(2), CBF index, and rCMRO(2) in human premature neonates' brains in the first six weeks of life Hum. Brain Mapp. 31341–352.352 (doi:10.1002/hbm.20868) doi: 10.1002/hbm.20868. [PMC free article] [PubMed] [Cross Ref]
18. Durduran T., et al. 2010. Optical measurement of cerebral hemodynamics and oxygen metabolism in neonates with congenital heart defects J. Biomed. Opt. 15037004. (doi:10.1117/1.3425884) doi: 10.1117/1.3425884. [PubMed] [Cross Ref]
19. Murkin J. M., Arango M. 2009. Near-infrared spectroscopy as an index of brain and tissue oxygenation Br. J. Anaesth. 103Suppl 1i3–i13.i13 (doi:10.1093/bja/aep299) doi: 10.1093/bja/aep299. [PubMed] [Cross Ref]
20. Highton D., Elwell C., Smith M. 2010. Noninvasive cerebral oximetry: is there light at the end of the tunnel? Curr. Opin. Anaesthesiol. 23576–581.581 (doi:10.1097/ACO.0b013e32833e1536) doi: 10.1097/ACO.0b013e32833e1536. [PubMed] [Cross Ref]
21. Hamaoka T., McCully K. K., Quaresima V., Yamamoto K., Chance B. 2007. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans J. Biomed. Opt. 12062105. (doi:10.1117/1.2805437) doi: 10.1117/1.2805437. [PubMed] [Cross Ref]
22. Kell R. T., Farag M., Bhambhani Y. 2004. Reliability of erector spinae oxygenation and blood volume responses using near-infrared spectroscopy in healthy males Eur. J. Appl. Physiol. 91499–507.507 (doi:10.1007/s00421-003-1014-0) doi: 10.1007/s00421-003-1014-0. [PubMed] [Cross Ref]
23. Austin K. G., Daigle K. A., Patterson P., Cowman J., Chelland S., Haymes E. M. Reliability of near-infrared spectroscopy for determining muscle oxygen saturation during exercise. Res. Q. Exerc. Sport. 2005;76:440–449. [PubMed]
24. Yu G., Durduran T., Zhou C., Yodh A. G., Lech G., Chance B., Mohler E. R., III 2005. Time-dependent blood flow and oxygenation in human skeletal muscles measured with noninvasive near-infrared diffuse optical spectroscopies J. Biomed. Opt. 10024027. (doi:10.1117/1.1884603) doi: 10.1117/1.1884603. [PubMed] [Cross Ref]
25. Belardinelli R. Monitoring skeletal muscle oxygenation during exercise by near infrared spectroscopy in chronic heart failure. Congest. Heart Fail. 1999;5:116–119. [PubMed]
26. McCully K. K., Landsberg L., Suarez M., Hofmann M., Posner J. D. 1997. Identification of peripheral vascular disease in elderly subjects using optical spectroscopy J. Gerontol. A Biol. Sci. Med. Sci. 52B159–165.165 (doi:10.1093/gerona/52A.3.B159) doi: 10.1093/gerona/52A.3.B159. [PubMed] [Cross Ref]
27. Cheatle T. R., Potter L. A., Cope M., Delpy D. T., Coleridge Smith P. D., Scurr J. H. 1991. Near-infrared spectroscopy in peripheral vascular disease Br. J. Surg. 78405–408.408 (doi:10.1002/bjs.1800780408) doi: 10.1002/bjs.1800780408. [PubMed] [Cross Ref]
28. De Blasi R. A., Cope M., Elwell C., Safoue F., Ferrari M. 1993. Noninvasive measurement of human forearm oxygen consumption by near infrared spectroscopy Eur. J. Appl. Physiol. Occup. Physiol. 6720–25.25 (doi:10.1007/BF00377698) doi: 10.1007/BF00377698. [PubMed] [Cross Ref]
29. Casavola C., Paunescu L. A., Fantini S., Gratton E. 2000. Blood flow and oxygen consumption with near-infrared spectroscopy and venous occlusion: spatial maps and the effect of time and pressure of inflation J. Biomed. Opt. 5269–276.276 (doi:10.1117/1.429995) doi: 10.1117/1.429995. [PubMed] [Cross Ref]
30. Brenner R. J. X-ray mammography and diaphanography in screening for breast cancer. J. Reprod. Med. 1982;27:679–684. [PubMed]
31. Drexler B., Davis J. L., Schofield G. Diaphanography in the diagnosis of breast cancer. Radiology. 1985;157:41–44. [PubMed]
32. Tromberg B. J., Shah N., Lanning R., Cerussi A., Esponoza J., Pham T., Svaasand L., Butler J. 2000. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy Neoplasia 226–40.40 (doi:10.1038/sj.neo.7900082) doi: 10.1038/sj.neo.7900082. [PMC free article] [PubMed] [Cross Ref]
33. Ntziachristos V., Chance B. 2001. Probing physiology and molecular function using optical imaging: applications to breast cancer Breast Cancer Res. 341–46.46 (doi:10.1186/bcr269) doi: 10.1186/bcr269. [PMC free article] [PubMed] [Cross Ref]
34. Heffer E., Pera V., Schutz O., Siebold H., Fantini S. 2004. Near-infrared imaging of the human breast: complementing hemoglobin concentration maps with oxygenation images J. Biomed. Opt. 91152–1160.1160 (doi:10.1117/1.1805552) doi: 10.1117/1.1805552. [PubMed] [Cross Ref]
35. Gibson A., Dehghani H. 2009. Diffuse optical imaging Phil. Trans. R. Soc. A 3673055–3072.3072 (doi:10.1098/rsta.2009.0080) doi: 10.1098/rsta.2009.0080. [PubMed] [Cross Ref]
36. Cerussi A., Shah N., Hsiang D., Durkin A., Butler J., Tromberg B. J. 2006. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy J. Biomed. Opt. 11044005. (doi:10.1117/1.2337546) doi: 10.1117/1.2337546. [PubMed] [Cross Ref]
37. Grosenick D., et al. 2004. Concentration and oxygen saturation of haemoglobin of 50 breast tumours determined by time-domain optical mammography Phys. Med. Biol. 491165–1181.1181 (doi:10.1088/0031-9155/49/7/006) doi: 10.1088/0031-9155/49/7/006. [PubMed] [Cross Ref]
38. Intes X. 2005. Time-domain optical mammography SoftScan: initial results Acad. Radiol. 12934–947.947 (doi:10.1016/j.acra.2005.05.006) doi: 10.1016/j.acra.2005.05.006. [PubMed] [Cross Ref]
39. Ntziachristos V., Yodh A. G., Schnall M. D., Chance B. 2002. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions Neoplasia 4347–354.354 (doi:10.1038/sj.neo.7900244) doi: 10.1038/sj.neo.7900244. [PMC free article] [PubMed] [Cross Ref]
40. Chance B., Nioka S., Zhang J., Conant E. F., Hwang E., Briest S., Orel S. G., Schnall M. D., Czerniecki B. J. 2005. Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study Acad. Radiol. 12925–933.933 (doi:10.1016/j.acra.2005.04.016) doi: 10.1016/j.acra.2005.04.016. [PubMed] [Cross Ref]
41. Carp S. A., Kauffman T., Fang Q., Boas D., Rafferty E., Moore R., Kopans D. 2006. Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements J. Biomed. Opt. 11064016. (doi:10.1117/1.2397572) doi: 10.1117/1.2397572. [PubMed] [Cross Ref]
42. Kuroda S., Houkin K., Abe H., Hoshi Y., Tamura M. 1996. Near-infrared monitoring of cerebral oxygenation state during carotid endarterectomy Surg. Neurol. 45450–458.458 (doi:10.1016/0090-3019(95)00463-7) doi: 10.1016/0090-3019(95)00463-7. [PubMed] [Cross Ref]
43. Samra S. K., Dy E. A., Welch K., Dorje P., Zelenock G. B., Stanley J. C. 2000. Evaluation of a cerebral oximeter as a monitor of cerebral ischemia during carotid endarterectomy Anesthesiology 93964–970.970 (doi:10.1097/00000542-200010000-00015) doi: 10.1097/00000542-200010000-00015. [PubMed] [Cross Ref]
44. Rigamonti A., Scandroqlio M., Minicucci F., Magrin S., Carozzo A., Casati A. 2005. A clinical evaluation of near-infrared cerebral oximetry in the awake patient to monitor cerebral perfusion during carotid endarterectomy J. Clin. Anesth. 17426–430.430 (doi:10.1016/j.jclinane.2004.09.007) doi: 10.1016/j.jclinane.2004.09.007. [PubMed] [Cross Ref]
45. Kuroda S., Houkin K., Abe H., Tamura M. 1996. Cerebral hemodynamic changes during carotid artery balloon occlusion monitored by near-infrared spectroscopy Neurol. Med. Chir. (Tokyo) 3678–86.86 (doi:10.2176/nmc.36.78) doi: 10.2176/nmc.36.78. [PubMed] [Cross Ref]
46. Kaminogo M., Ochi M., Onizuka M., Takahata H., Shibata S. 1999. An additional monitoring of regional cerebral oxygen saturation to HMPAO SPECT study during balloon test occlusion Stroke 30407–413.413 (doi:10.1161/01.STR.30.2.407) doi: 10.1161/01.STR.30.2.407. [PubMed] [Cross Ref]
47. Calderon-Arnulphi M., Alaraj A., Amin-Hanjani S., Mantulin W. W., Polzonetti C. M., Gratton E., Charbel F. T. 2007. Detection of cerebral ischemia in neurovascular surgery using quantitative frequency-domain near-infrared spectroscopy J. Neurosurg. 106283–290.290 (doi:10.3171/jns.2007.106.2.283) doi: 10.3171/jns.2007.106.2.283. [PubMed] [Cross Ref]
48. Kakihana Y., Matsunaga A., Yasuda T., Imabayashi T., Kanmura Y., Tamura M. 2008. Brain oxymetry in the operating room: current status and future directions with particular regard to cytochrome oxidase J. Biomed. Opt. 13033001. (doi:10.1117/1.2940583) doi: 10.1117/1.2940583. [PubMed] [Cross Ref]
49. Toet M. C., Flinterman A., van de Laar I., de Vries J. W., Bennink G. B. W. E., Uiterwaal C. S. P. M., van Bel F. 2005. Cerebral oxygen saturation and electrical brain activity before, during, and up to 36 hours after arterial switch procedure in neonates without pre-existing brain damage: its relationship to neurodevelopmental outcome Exp. Brain Res. 165343–350.350 (doi:10.1007/s00221-005-2300-3) doi: 10.1007/s00221-005-2300-3. [PubMed] [Cross Ref]
50. Razumovsky A. Y., Gugino L. D., Owen J. H. 2006. Advanced neurologic monitoring for cardiac surgery Curr. Cardiol. Rep. 817–22.22 (doi:10.1007/s11886-006-0005-2) doi: 10.1007/s11886-006-0005-2. [PubMed] [Cross Ref]
51. Murkin J. M., et al. 2007. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study Anesth. Analg. 10451–58.58 (doi:10.1213/01.ane.0000246814.29362.f4) doi: 10.1213/01.ane.0000246814.29362.f4. [PubMed] [Cross Ref]
52. Ohmae E., Oda M., Suzuki T., Yamashita Y., Kakihana Y., Matsunaga A., Kanmura Y., Tamura M. 2007. Clinical evaluation of time-resolved spectroscopy by measuring cerebral hemodynamics during cardiopulmonary bypass surgery J. Biomed. Opt. 12062112. (doi:10.1117/1.2804931) doi: 10.1117/1.2804931. [PubMed] [Cross Ref]
53. Fedorow C., Grocott H. P. 2010. Cerebral monitoring to optimize outcomes after cardiac surgery Curr. Opin. Anaesthesiol. 2389–94.94 (doi:10.1097/ACO.0b013e3283346d10) doi: 10.1097/ACO.0b013e3283346d10. [PubMed] [Cross Ref]
54. Wardle S. P., Yoxall C. W., Weindling A. M. 2000. Determinants of cerebral fractional oxygen extraction using near infrared spectroscopy in preterm neonates J. Cereb. Blood Flow. Metab 20272–279.279 (doi:10.1097/00004647-200002000-00008) doi: 10.1097/00004647-200002000-00008. [PubMed] [Cross Ref]
55. Zaramella P., Saraceni E., Freato F., Faicon E., Suppiei A., Milan A., Laverda A. M., Chiandetti L. 2007. Can tissue oxygenation index (TOI) and cotside neurophysiological variables predict outcome in depressed/asphyxiated newborn infants? Early Hum. Dev. 83483–489.489 (doi:10.1016/j.earlhumdev.2006.09.003) doi: 10.1016/j.earlhumdev.2006.09.003. [PubMed] [Cross Ref]
56. Sorensen L. C., Maroun L. L., Borch K., Lou H. C., Greisen G. 2008. Neonatal cerebral oxygenation is not linked to foetal vasculitis and predicts intraventricular haemorrhage in preterm infants Acta Paediatr. 971529–1534.1534 (doi:10.1111/j.1651-2227.2008.00970.x) doi: 10.1111/j.1651-2227.2008.00970.x. [PubMed] [Cross Ref]
57. Greisen G. 2006. Is near-infrared spectroscopy living up to its promises? Semin. Fetal Neonatal Med. 11498–502.502 (doi:10.1016/j.siny.2006.07.010) doi: 10.1016/j.siny.2006.07.010. [PubMed] [Cross Ref]
58. Dullenkopf A., Kolarova A., Schulz G., Frey B., Baenziger O., Weiss M. 2005. Reproducibility of cerebral oxygenation measurement in neonates and infants in the clinical setting using the NIRO 300 oximeter Pediatr. Crit. Care Med. 6344–347.347 (doi:10.1097/01.PCC.0000161282.69283.75) doi: 10.1097/01.PCC.0000161282.69283.75. [PubMed] [Cross Ref]
59. Reynolds E. O., Wyatt J. S., Azzopardi D., Delpy D. T., Cady E. B., Cope M., Wray S. New non-invasive methods for assessing brain oxygenation and haemodynamics. Br. Med. Bull. 1988;44:1052–1075. [PubMed]
60. Wyatt J. S., Edwards A. D., Cope M., Delpy D. T., McCormick D. C., Potter A., Reynolds E. O. 1991. Response of cerebral blood volume to changes in arterial carbon dioxide tension in preterm and term infants Pediatr. Res. 29553–557.557 (doi:10.1203/00006450-199106010-00007) doi: 10.1203/00006450-199106010-00007. [PubMed] [Cross Ref]
61. Yoxall C., Weindling A. M., Dawani N. H., Peart I. Measurement of cerebral venous oxyhemoglobin saturation in children by near-infrared spectroscopy and partial jugular venous occlusion. Pediatr. Res. 1995;38:319–323. [PubMed]
62. Cooper C. E., Elwell C. E., Meek J. H., Matcher S. J., Wyatt J. S., Cope M., Delpy D. T. 1996. The noninvasive measurement of absolute cerebral deoxyhemoglobin concentration and mean optical path length in the neonatal brain by second derivative near infrared spectroscopy Pediatr. Res. 3932–38.38 (doi:10.1203/00006450-199601000-00005) doi: 10.1203/00006450-199601000-00005. [PubMed] [Cross Ref]
63. Fantini S., Franceschini M. A., Fishkin J. B., Barbieri B., Gratton E. 1994. Quantitative determination of the absorption spectra of chromophores in strongly scattering media: a light-emitting-diode based technique Appl. Opt. 335204–5213.5213 (doi:10.1364/AO.33.005204) doi: 10.1364/AO.33.005204. [PubMed] [Cross Ref]
64. Franceschini M. A., Thaker S., Themelis G., Krishnamoorthy K. K., Bortfeld H., Diamond S. G., Boas D. A., Arvin K., Grant P. E. Assessment of infant brain development with frequency-domain near-infrared spectroscopy. Pediatr. Res. 1994;61:546–551. [PMC free article] [PubMed]
65. Leung T. S., Tachtsidis I., Tisdall M. M., Pritchard C., Smith M., Elwell C. E. 2009. Estimating a modified Grubb's exponent in healthy human brains with near infrared spectroscopy and transcranial Doppler Physiol. Meas. 301–12.12 (doi:10.1088/0967-3334/30/1/001) doi: 10.1088/0967-3334/30/1/001. [PubMed] [Cross Ref]
66. Boas D. A., Payne S. J. 2009. Comment on ‘Estimating a modified Grubb's exponent in healthy human brains with near infrared spectroscopy and transcranial Doppler’ Physiol. Meas 30L9–L11.L11author reply L13–L14 (doi:10.1088/0967-3334/30/10/L01) doi: 10.1088/0967-3334/30/10/L01. [PubMed] [Cross Ref]
67. Grubb R. L., Jr, Dehner L. P. 1974. Congenital fibrosarcoma of the thoracolumbar region J. Pediatr. Surg. 9785–786.786 (doi:10.1016/0022-3468(74)90120-1) doi: 10.1016/0022-3468(74)90120-1. [PubMed] [Cross Ref]
68. Chen J. J., Pike G. B. 2010. MRI measurement of the BOLD-specific flow-volume relationship during hypercapnia and hypocapnia in humans Neuroimage 53383–391.391 (doi:10.1016/j.neuroimage.2010.07.003) doi: 10.1016/j.neuroimage.2010.07.003. [PubMed] [Cross Ref]
69. Zhou C., et al. 2007. Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy J. Biomed. Opt. 12051903. (doi:10.1117/1.2798595) doi: 10.1117/1.2798595. [PubMed] [Cross Ref]
70. Jakubowski D. B., Cerussi A. E., Bevilacqua F., Shah N., Hsiang D., Butler J., Tromberg B. J. 2004. Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study J. Biomed. Opt. 9230–238.238 (doi:10.1117/1.1629681) doi: 10.1117/1.1629681. [PubMed] [Cross Ref]
71. Takahashi T., Shirane R., Sato S., Yoshimoto T. Developmental changes of cerebral blood flow and oxygen metabolism in children. AJNR Am. J. Neuroradiol. 1999;20:917–922. [PubMed]
72. Yaseen M. A., Srinivasan V. J., Sakadiæ S., Radhakrishnan H., Gorczynska I., Wu W., Fujimoto J. G., Boas D. A. 2011. Microvascular oxygen tension and flow measurements in rodent cerebral cortex during baseline conditions and functional activation J. Cereb. Blood Flow Metab. 311051–1063.1063 (doi:10.1038/jcbfm.2010.227) doi: 10.1038/jcbfm.2010.227. [PMC free article] [PubMed] [Cross Ref]
Articles from Philosophical transactions. Series A, Mathematical, physical, and engineering sciences are provided here courtesy of
The Royal Society